Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease

By sjmartinez • October 21, 2022

Nee R, Yuan CM, Narva AS, Yan G, Norris KC. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease. Nephrol Dial Transplant. 2022 Oct 20:gfac283. doi: 10.1093/ndt/gfac283. Epub ahead of print. PMID: 36264305.

Tags: cardiovascular disease, Chronic kidney disease, diabetes mellitus, glucagon-like peptide-1 receptor agonist, Nephrology, nonsteroidal mineralocorticoid receptor antagonist, Publications, sodium-glucose cotransporter-2 inhibitor

Practices in the Management of Kidney Transplant Candidates and Recipients with Obesity: A Survey of U.S. Transplant Programs

Puttarajappa CM, Urbanski M, Fallahzadeh MK, Budhiraja P, Balaraman V, Butsch WS, Morford H, Anand PM, Woodside KJ, Orandi BJ; co-authors; American Society of Transplantation[...]

A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular Events, and Terminal Event in Patients with Chronic Kidney Disease

Kürüm E, Kwan B, Qian Q, Banerjee S, Rhee CM, Nguyen DV, Şentürk D. A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular[...]

Improvement of Kidney Function Following Unilateral Nephrectomy in a Patient With Cardiovascular-Kidney-Metabolic (CKM) Syndrome

Asopa M, Kamgar M, Wilson J, Emami S, Shuch B, Nobakht N. Improvement of Kidney Function Following Unilateral Nephrectomy in a Patient With Cardiovascular-Kidney-Metabolic (CKM)[...]